| 24391143 | Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance. | Mol Cancer Res | 2014 Apr | Zou JX | doi: 10.1158/1541-7786.MCR-13-0459 |
| 20374707 | The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer. | Prog Mol Biol Transl Sci | 2009 | Hsia EY | doi: 10.1016/S1877-1173(09)87008-7 |
| 19318566 | Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer. | Cancer Res | 2009 Apr 15 | Zou JX | doi: 10.1158/0008-5472.CAN-08-3440 |
| 25813398 | Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer. | Oncol Rep | 2015 May | Zheng L | doi: 10.3892/or.2015.3867 |
| 26527032 | ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker. | Clin Transl Oncol | 2016 Aug | Zhang M | doi: 10.1007/s12094-015-1430-8 |
| 17998543 | ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. | Proc Natl Acad Sci U S A | 2007 Nov 13 | Zou JX | - |
| 20864510 | ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. | Cancer Res | 2010 Nov 15 | Kalashnikova EV | doi: 10.1158/0008-5472.CAN-10-1199 |
| 26308378 | ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma. | Oncotarget | 2015 Sep 29 | Krakstad C | doi: 10.18632/oncotarget.4955. |
| 26819280 | ATAD2 overexpression is associated with progression and prognosis in colorectal cancer. | Jpn J Clin Oncol | 2016 Mar | Hou M | doi: 10.1093/jjco/hyv195 |
| 27612420 | ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication. | Oncotarget | 2016 Oct 25 | Koo SJ | doi: 10.18632/oncotarget.11855. |
| 28591577 | Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer. | Cell Rep | 2017 Jun 6 | Urbanucci A | doi: 10.1016/j.celrep.2017.05.049. |
| 27565322 | Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells. | Neoplasma | 2016 | Hong S | - |
| 29958090 | ATAD2 silencing decreases VEGFA secretion through targeting has-miR-520a to inhibit angiogenesis in colorectal cancer. | Biochem Cell Biol | 2018 Dec | Hong S | doi: 10.1139/bcb-2018-0081 |
